Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
This page is not indexed by search engines while we improve data quality.
Moreno Jesus — Human Necessities
Moreno Jesus holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Moreno Jesus |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2022 |
| Last year | 2022 |
Representative patents
Notable publications linking Moreno Jesus to Human Necessities.
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Recent filings
Latest patents from Moreno Jesus in Human Necessities.
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
US-2022040184-A1 · Feb 10, 2022 · US
Related pages
Navigate to parent entity pages.